TALVEY 3MG INJECTION

About TALVEY 3MG INJECTION

Talvey 3MG Injection contains talquetamab 3mg. It connects T-cells to GPRC5D on myeloma cells so the T-cells kill them, which is why it is classed as a GPRC5D x CD3 bispecific antibody (immunotherapy). Specialists use it for relapsed or refractory multiple myeloma after several earlier lines. During treatment expect regular checks such as cytokine release syndrome, taste changes, skin and nail problems. Made by Johnson & Johnson; pack size 1 vial. MRP Rs 40,000 as per the NPPA revision of 9 November 2026. Never start, stop or change it on your own - the oncologist or specialist decides the plan.